You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma

  • Technology appraisal guidance
  • Reference number: TA306
  • Published:  26 February 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document
31 December 2013
(417.01 Kb 1 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 20 December 2013

Back to top